Cell atlases and human studies reveal candidate cell-specific signals in brain disease
PsychAD reported a postmortem atlas of over 6.3 million nuclei from 1,494 donors across eight diseases, while a mouse Alzheimer’s protein atlas found over 3,000 altered proteins and RNA–protein mismatches; these resources do not establish therapeutic targets. A new human Alzheimer’s study adds hypothalamic nuclei and cell types through HypoAD, highlighting circadian and inflammatory signals and altered SCN vasopressin signaling as exploratory leads. Its small post-mortem cohort and limited AD-specific MRI findings warrant larger-cohort follow-up.
Sources (3)
Updated Nov 18, 2026